Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1965 2
1966 2
1967 5
1968 7
1969 4
1970 2
1971 6
1972 14
1973 12
1974 14
1975 8
1976 9
1977 6
1978 8
1979 8
1980 25
1981 13
1982 15
1983 13
1984 18
1985 20
1986 26
1987 22
1988 42
1989 28
1990 34
1991 34
1992 35
1993 76
1994 49
1995 79
1996 82
1997 48
1998 54
1999 68
2000 88
2001 75
2002 79
2003 65
2004 69
2005 66
2006 81
2007 73
2008 69
2009 103
2010 95
2011 93
2012 102
2013 104
2014 106
2015 135
2016 120
2017 147
2018 148
2019 126
2020 160
2021 186
2022 188
2023 237
2024 96

Text availability

Article attribute

Article type

Publication date

Search Results

1,374 results

Results by year

Filters applied: Meta-Analysis, Review, Systematic Review, in the last 10 years. Clear all
Page 1
Hypertrophic cardiomyopathy: the future of treatment.
Tuohy CV, Kaul S, Song HK, Nazer B, Heitner SB. Tuohy CV, et al. Eur J Heart Fail. 2020 Feb;22(2):228-240. doi: 10.1002/ejhf.1715. Epub 2020 Jan 9. Eur J Heart Fail. 2020. PMID: 31919938 Free article. Review.
Hypertrophic cardiomyopathy (HCM) is a heterogeneous genetic disorder most often caused by sarcomeric mutations resulting in left ventricular hypertrophy, fibrosis, hypercontractility, and reduced compliance. ...
Hypertrophic cardiomyopathy (HCM) is a heterogeneous genetic disorder most often caused by sarcomeric mutations resulting in l …
Hypertrophic Cardiomyopathy: An Overview of Genetics and Management.
Teekakirikul P, Zhu W, Huang HC, Fung E. Teekakirikul P, et al. Biomolecules. 2019 Dec 16;9(12):878. doi: 10.3390/biom9120878. Biomolecules. 2019. PMID: 31888115 Free PMC article. Review.
Hypertrophic cardiomyopathy (HCM) is a genetically heterogeneous cardiac muscle disorder with a diverse natural history, characterized by unexplained left ventricular hypertrophy (LVH), with histopathological hallmarks including myocyte enlargement, myocyte disarray …
Hypertrophic cardiomyopathy (HCM) is a genetically heterogeneous cardiac muscle disorder with a diverse natural history, chara …
Hypertrophic Cardiomyopathy: Clinical Update.
Geske JB, Ommen SR, Gersh BJ. Geske JB, et al. JACC Heart Fail. 2018 May;6(5):364-375. doi: 10.1016/j.jchf.2018.02.010. Epub 2018 Apr 11. JACC Heart Fail. 2018. PMID: 29655825 Free article. Review.
Hypertrophic cardiomyopathy (HCM) is the most common heritable cardiomyopathy, manifesting as left ventricular hypertrophy in the absence of a secondary cause. ...
Hypertrophic cardiomyopathy (HCM) is the most common heritable cardiomyopathy, manifesting as left ventricular hypertrophy in …
Hypertrophic cardiomyopathy.
Antunes MO, Scudeler TL. Antunes MO, et al. Int J Cardiol Heart Vasc. 2020 Mar 25;27:100503. doi: 10.1016/j.ijcha.2020.100503. eCollection 2020 Apr. Int J Cardiol Heart Vasc. 2020. PMID: 32309534 Free PMC article. Review.
Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiac disease. ...
Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiac disease. ...
Management of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review.
Maron BJ, Desai MY, Nishimura RA, Spirito P, Rakowski H, Towbin JA, Dearani JA, Rowin EJ, Maron MS, Sherrid MV. Maron BJ, et al. J Am Coll Cardiol. 2022 Feb 1;79(4):390-414. doi: 10.1016/j.jacc.2021.11.021. J Am Coll Cardiol. 2022. PMID: 35086661 Free article.
Hypertrophic cardiomyopathy (HCM), a relatively common, globally distributed, and often inherited primary cardiac disease, has now transformed into a contemporary highly treatable condition with effective options that alter natural history along specific personalize …
Hypertrophic cardiomyopathy (HCM), a relatively common, globally distributed, and often inherited primary cardiac disease, has …
Circulating Biomarkers in Hypertrophic Cardiomyopathy.
Matthia EL, Setteducato ML, Elzeneini M, Vernace N, Salerno M, Kramer CM, Keeley EC. Matthia EL, et al. J Am Heart Assoc. 2022 Dec 6;11(23):e027618. doi: 10.1161/JAHA.122.027618. Epub 2022 Nov 16. J Am Heart Assoc. 2022. PMID: 36382968 Free PMC article. Review.
Hypertrophic cardiomyopathy is the most common genetic heart disease. ...We present an updated review of circulating biomarkers in hypertrophic cardiomyopathy representing key pathologic processes including wall stretch, myocardial necrosis, fibrosis, …
Hypertrophic cardiomyopathy is the most common genetic heart disease. ...We present an updated review of circulating biomarker …
Hypertrophic Cardiomyopathy: New Concepts and Therapies.
Maron BJ, Rowin EJ, Maron MS. Maron BJ, et al. Annu Rev Med. 2022 Jan 27;73:363-375. doi: 10.1146/annurev-med-042220-021539. Annu Rev Med. 2022. PMID: 35084989 Review.
Hypertrophic cardiomyopathy (HCM), a relatively common, globally distributed, and often inherited myocardial disorder, transformed over the last several years into a treatable condition with the emergence of effective management options that alter natural history at …
Hypertrophic cardiomyopathy (HCM), a relatively common, globally distributed, and often inherited myocardial disorder, transfo …
Diagnosis and Evaluation of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review.
Maron BJ, Desai MY, Nishimura RA, Spirito P, Rakowski H, Towbin JA, Rowin EJ, Maron MS, Sherrid MV. Maron BJ, et al. J Am Coll Cardiol. 2022 Feb 1;79(4):372-389. doi: 10.1016/j.jacc.2021.12.002. J Am Coll Cardiol. 2022. PMID: 35086660 Free article.
Hypertrophic cardiomyopathy (HCM) is a relatively common often inherited global heart disease, with complex phenotypic and genetic expression and natural history, affecting both genders and many races and cultures. ...
Hypertrophic cardiomyopathy (HCM) is a relatively common often inherited global heart disease, with complex phenotypic and gen …
Hypertrophic cardiomyopathy.
Santos Mateo JJ, Sabater Molina M, Gimeno Blanes JR. Santos Mateo JJ, et al. Med Clin (Barc). 2018 Jun 8;150(11):434-442. doi: 10.1016/j.medcli.2017.09.013. Epub 2017 Nov 14. Med Clin (Barc). 2018. PMID: 29150126 Review. English, Spanish.
Hypertrophic cardiomyopathy is the most common inherited cardiovascular disease. ...It is caused by mutations in sarcomeric proteins, which are identified in up to 60% of cases of the disease. Clinical manifestations of Hypertrophic Cardiomyopathy incl …
Hypertrophic cardiomyopathy is the most common inherited cardiovascular disease. ...It is caused by mutations in sarcomeric pr …
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P, Evanovich LL, Hung J, Joglar JA, Kantor P, Kimmelstiel C, Kittleson M, Link MS, Maron MS, Martinez MW, Miyake CY, Schaff HV, Semsarian C, Sorajja P. Ommen SR, et al. Circulation. 2020 Dec 22;142(25):e533-e557. doi: 10.1161/CIR.0000000000000938. Epub 2020 Nov 20. Circulation. 2020. PMID: 33215938 Free article. Review.
Aim This executive summary of the hypertrophic cardiomyopathy clinical practice guideline provides recommendations and algorithms for clinicians to diagnose and manage hypertrophic cardiomyopathy in adult and pediatric patients as well as supporting do …
Aim This executive summary of the hypertrophic cardiomyopathy clinical practice guideline provides recommendations and algorit …
1,374 results